![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-9580e95adb017aa652590021859ad95f24a73d7bfccee4970f72aea5273d4848.jpg)
Ondansetron in Patients Requiring Anti-Emetics: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.